TAVI with ACURATE neo2 vs. Sapien/Evolut: A SWEDEHEART Target Trial Emulation Study

Sunday, March 9, 2025

2:39 PM – 2:49 PM ET

Speaker(s)

Andreas Rück, MD, PhD

Senior Consultant
Karolinska University Hospital, Sweden

Disclosure(s): Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Andreas Rück, MD, PhD: Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)